As the SOC entry is considered to be primary Ca2+ entry mechanism in most cancer types (thus contributing to cancer cell migration, invasiveness, and metastasis), there is a high interest in development of selective SOC entry blockers to prevent cancer metastasis [52,53]. This evidence concerns the gene UBXN11 and cancer.